Page last updated: 2024-08-17

triiodothyronine and oxytetracycline, anhydrous

triiodothyronine has been researched along with oxytetracycline, anhydrous in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Huang, L; Li, X; Qiu, Y; Wang, W; Yi, X; Yu, K; Yu, X; Zeng, X1
Cai, K; Huang, L; Li, H; Qiu, Y; Wang, W; Xu, S; Yi, X; Yu, K; Yu, X1

Reviews

1 review(s) available for triiodothyronine and oxytetracycline, anhydrous

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for triiodothyronine and oxytetracycline, anhydrous

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Low-dose effects on thyroid disruption in zebrafish by long-term exposure to oxytetracycline.
    Aquatic toxicology (Amsterdam, Netherlands), 2020, Volume: 227

    Topics: Animals; Endocrine Disruptors; Oxytetracycline; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine; Water Pollutants, Chemical; Zebrafish

2020
Long-term low-dose oxytetracycline potentially leads to neurobehavioural changes.
    Ecotoxicology and environmental safety, 2021, Oct-15, Volume: 223

    Topics: Animals; Anti-Bacterial Agents; Molecular Docking Simulation; Oxytetracycline; Triiodothyronine; Zebrafish

2021